share_log

Illumina | 8-K: Current report

Illumina | 8-K: Current report

Illumina | 8-K：重大事件
美股SEC公告 ·  2024/06/03 22:27

Moomoo AI 已提取核心訊息

Illumina's board has approved the spin-off of GRAIL, with the distribution scheduled for June 24, 2024. Shareholders will receive one GRAIL share for every six Illumina shares held as of June 13, 2024. GRAIL will begin trading on Nasdaq under "GRAL" symbol on June 25, 2024, with Illumina distributing at least 85.5% of GRAIL's common stock.The company expects to incur charges of $35-50 million, primarily for legal and advisory fees related to the spin-off, with most expenses occurring in Q2 2024. The spin-off approval triggers a potential goodwill impairment test in Q2 2024. As of March 31, 2024, GRAIL-related assets include $1.47B in goodwill, $561M in non-amortizing R&D, and $2.09B in amortizing intangible assets.The distribution requires no shareholder vote or payment, though investors are advised to consult financial advisors regarding trading implications. Prior to the spin-off, GRAIL, LLC will be converted to GRAIL, Inc., a Delaware corporation. The distribution remains subject to conditions outlined in GRAIL's Form 10 registration statement.
Illumina's board has approved the spin-off of GRAIL, with the distribution scheduled for June 24, 2024. Shareholders will receive one GRAIL share for every six Illumina shares held as of June 13, 2024. GRAIL will begin trading on Nasdaq under "GRAL" symbol on June 25, 2024, with Illumina distributing at least 85.5% of GRAIL's common stock.The company expects to incur charges of $35-50 million, primarily for legal and advisory fees related to the spin-off, with most expenses occurring in Q2 2024. The spin-off approval triggers a potential goodwill impairment test in Q2 2024. As of March 31, 2024, GRAIL-related assets include $1.47B in goodwill, $561M in non-amortizing R&D, and $2.09B in amortizing intangible assets.The distribution requires no shareholder vote or payment, though investors are advised to consult financial advisors regarding trading implications. Prior to the spin-off, GRAIL, LLC will be converted to GRAIL, Inc., a Delaware corporation. The distribution remains subject to conditions outlined in GRAIL's Form 10 registration statement.
生物技術公司illumina宣佈董事會批准分拆旗下子公司GRAIL，分拆將以比例股利的方式向illumina股東派發GRAIL至少85.5%的普通股。此分配計劃在2024年6月24日，美國東部時間上午12:01生效，隔日GRAIL將開始在納斯達克全球精選市場上市，股票代碼為“GRAL”。illumina的股東，在記錄日期2024年6月13日，將按照每6股illumina股份換發1股GRAIL股票。GRAIL在美國證券交易委員會（SEC）的10號申報書中以特定條件為前提進行分拆。與分拆相關，illumina預計將承擔3500萬至5000萬美元的費用，主要是法律和顧問費用，其中大部分費用預計在20...展開全部
生物技術公司illumina宣佈董事會批准分拆旗下子公司GRAIL，分拆將以比例股利的方式向illumina股東派發GRAIL至少85.5%的普通股。此分配計劃在2024年6月24日，美國東部時間上午12:01生效，隔日GRAIL將開始在納斯達克全球精選市場上市，股票代碼為“GRAL”。illumina的股東，在記錄日期2024年6月13日，將按照每6股illumina股份換發1股GRAIL股票。GRAIL在美國證券交易委員會（SEC）的10號申報書中以特定條件為前提進行分拆。與分拆相關，illumina預計將承擔3500萬至5000萬美元的費用，主要是法律和顧問費用，其中大部分費用預計在2024年第二季度產生，其餘費用在第三季度產生。此外，分拆可能導致illumina的商譽損失，並可能於2024年第二季度的中期測試後確認。截至2024年3月31日，該公司的資產負債表顯示，商譽金額為14.66億美元，非攤銷的研究和開發費用為5.61億美元，淨攤銷無形資產與GRAIL有關為20.92億美元。

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Exagen
    XGN
    -- 3.990
    Atlantic International
    ATLN
    -- 5.650
    Neuronetics
    STIM
    -- 2.460
    XWELL Inc
    XWEL
    -- 1.2500
    Precipio
    PRPO
    -- 6.5100

    解鎖榜首股票

    熱門討論
    特朗普2.0時代開啓，全球股市新風口在哪裏？
    ▪️加密貨幣政策能否利好crypto? ▪️關稅政策能否利好中概等海外資產？ ▪️在特朗普政策下，有哪些投資機會值得關注？ 展开
    離川普上臺只有7天了～